PWMG
FLGT icon

Prestige Wealth Management Group’s Fulgent Genetics FLGT Stock Holding History

Prestige Wealth Management Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-84
Closed -$5K – 996
2022
Q2 		$5K Hold
84
– – ﹤0.01% 576
2022
Q1 		$5K Hold
84
– – ﹤0.01% 607
2021
Q4 		$8K Sell
84
-1
-1% -$88 ﹤0.01% 524
2021
Q3 		$8K Hold
85
– – ﹤0.01% 529
2021
Q2 		$8K Hold
85
– – ﹤0.01% 521
2021
Q1 		$8K Sell
85
-3
-3% -$310 ﹤0.01% 519
2020
Q4 		$5K Buy
+88
New +$3.68K ﹤0.01% 578

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prestige Wealth Management Group's FLGT Position: Q3 2022 in Review

Prestige Wealth Management Group sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 84 shares — an estimated $5K sold.

Prestige Wealth Management Group first reported a position in FLGT in Q4 2020 and held it in 7 quarters. The position peaked at $8K in Q4 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Prestige Wealth Management Group reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Prestige Wealth Management Group sold 84 Fulgent Genetics shares in Q3 2022, an estimated $5K.
  • Prestige Wealth Management Group first reported a position in Fulgent Genetics in Q4 2020 and held it in 7 quarters.
  • Prestige Wealth Management Group's Fulgent Genetics position peaked at $8K in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Prestige Wealth Management Group's 13F filing for Q3 2022, filed 1 Nov 2022.